Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




2013 Online Pathology Progress Test Now Available

By LabMedica International staff writers
Posted on 17 Dec 2013
The 2013 version of the main exam for progress monitoring and for evaluating and establishing training standards in pathology across Europe is now available.

As of November 25, the 2013 EUROPALS annual pathology test is now available, offered by the European Society of Pathology (ESP) in close collaboration with the European Association of Pathology Chairs & Program Directors (EAPCP). More...
The 2013 test coordinator is Prof. Dr. Fred T. Bosman. It is especially intended for trainees but all ESP member pathologists are free to participate.

The test consists of 100 questions, partly straight, multiple choice questions, partly still-image based and partly virtual-slide based, and extended matching questions. The chosen level is that of a trainee at the end of a residency program. The test comprises of questions with a purely diagnostic orientation, molecular pathology test items, and mechanism of disease-oriented questions.

The test is preferably to be done in one run but can be done in parts if needed. It generally takes approximately 2–2.5 hours in total. A score result will be provided to the test-taker immediately upon completion of the exam. The test is formative—a tool for self-assessment. The results are kept anonymous.

The exam can be taken by logging on to the online (please see Related Links below) with one’s own password; for those without a password, one can be obtained on the website. All existing users are requested to update their Year of Training and Country from “My Account -> Your Details” once logged into PathXL.

Please note prior to taking the test that it is highly recommended to upgrade to the latest versions of Internet Explorer (v9 or v10), Firefox (v24), Google Chrome (v30) or Safari (v5.1.7) for optimal performance and experience. Problems may be experienced using unsupported browsers, such as older versions of Internet Explorer. Tablets or mobile devices are not supported for the test.

Related Links:

European Society of Pathology
Pathxl
EUROPALS Annual Pathology Test



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.